Immunotherapy for Autoimmune Disorders
Innovations and Insights
- 1st Edition - October 1, 2026
- Latest edition
- Editors: Arun Kumar Singh, Nagaraju Bandaru, Vasso Apostolopoulos, Ashutosh Pareek, Murali M. Yallapu
- Language: English
Immunotherapy for Autoimmune Disorders: Innovations and Insights revolutionizes the therapeutic paradigm for autoimmune illnesses, offering new perspectives over traditional medica… Read more
World Book Day celebration
Where learning shapes lives
Up to 25% off trusted resources that support research, study, and discovery.
Description
Description
Key features
Key features
- Provides in-depth knowledge on the pathophysiology, diagnosis, and treatment of autoimmune diseases
- Explores cutting-edge immunotherapy techniques and their applications in autoimmune disorder treatment
- Bridges the gap between scientific research and clinical practice for better patient management
- Enhances academic and clinical research through detailed case studies and clinical trial findings
- Fosters collaboration among medical professionals, researchers, and policymakers for innovative treatment solutions
Readership
Readership
Table of contents
Table of contents
2. The Immunopathogenesis of Autoimmune Diseases
3. Monoclonal Antibodies in Autoimmune Disease Treatment
4. Immune Checkpoint Inhibitors in Autoimmunity
5. T-cell Modulation Therapies
6. Cytokine Targeting Therapies
7. B-cell Depletion Strategies
8. Adoptive Cell Transfer and Regulatory T Cells
9. Immunomodulatory Agents and Small Molecules
10. Personalized Immunotherapy Approaches
11. Immunotherapy in Specific Autoimmune Diseases
12. Future Directions and Emerging Therapies in Immunotherapy for Autoimmune Disorders
13. Regulatory and Ethical Considerations in Autoimmunotherapy Application
Product details
Product details
- Edition: 1
- Latest edition
- Published: October 1, 2026
- Language: English
About the editors
About the editors
AS
Arun Kumar Singh
Arun Kumar Singh holds an M.Pharm in Pharmaceutics from Galgotias University, India, and serves as an Assistant Professor in the Department of Pharmacy at Vivekanand Global University. He is actively engaged in teaching and interdisciplinary research spanning nano-formulation, artificial intelligence, machine learning, big data analytics, IoT, blockchain, cancer biology, and neuroscience.
Mr. Singh has made substantial scholarly contributions, authoring one book with IOP Publishing, five book chapters with River Publishers, and 28 review articles in reputed journals, including high-impact publications in Biochimica et Biophysica Acta (BBA) – Reviews on Cancer.
In addition, he has authored and edited 58 books with leading publishers such as Elsevier, CRC Press, and Wiley. Known for his research acumen and leadership, Mr. Singh is committed to advancing pharmaceutical sciences through innovation and interdisciplinary collaboration, with a focus on impactful healthcare solutions.
NB
Nagaraju Bandaru
VA
Vasso Apostolopoulos
Professor Vasso Apostolopoulos is a Distinguished Professor at RMIT University, Australia. She received her PhD in immunology in 1995 from the University of Melbourne and the Advanced Certificate in Protein Crystallography from Birkbeck College, University of London. Professor Vasso Apostolopoulos is a world-renowned researcher who has been recognized with over 100 awards for the outstanding results of her research. She has published over 500 research publications, 8 books, and 33 book chapters, is a sought-after keynote speaker at conferences, is an inventor on 21 patents, and has over 22,000 citations.
AP
Ashutosh Pareek
Dr. Ashutosh Pareek, Professor at Banasthali Vidyapith with over 15 years of experience in pharmaceutical sciences, holds gold medals for his Master's and Bachelor's degrees in Pharmacy. Dr. Pareek specializes in neuropharmacology and innovative drug delivery systems, focusing on neurodegenerative disorders, cancer, and autoimmune diseases. His research includes developing advanced drug delivery systems for immunomodulators like naringenin. Dr. Pareek leads a research team working on these critical health issues and has published over 45 research papers and authored five technical books. He holds an international formulation patent and has received numerous awards, including the Zee National Achievers Award 2023. His work is funded by national and international agencies such as ICMR, DST-SERB, DBT, the American Association of Pharmaceutical Scientists, and the International Brain Research Organization. He serves as a Review Editor for Frontiers in Pharmacology and Frontiers in Oncology and reviews for leading journals by Elsevier, Springer, and Bentham.
MY
Murali M. Yallapu
Dr. Murali Yallapu is a tenured Associate Professor at the University of Texas Rio Grande Valley's School of Medicine, specializing in Immunology, Microbiology, and Oncology and a member of the South Texas Center of Excellence in Cancer Research. Dr. Yallapu received the "Prof. A. Kameswara Rao's Gold Medal-1999" and completed postdoctoral training in materials science, drug delivery, nanomedicine, and cancer biology at institutions including the Cleveland Clinic and the University of Nebraska Medical Center. Before joining UTRGV, he was an Assistant Professor at the University of Tennessee Health Science Center. Dr. Yallapu serves on editorial boards for various journals related to drug delivery, nanotechnology, and cancer, and is an ad-hoc reviewer for the NIH and other funding agencies. He has published over 190 peer-reviewed articles and reviews. His primary research focuses on developing nanomaterials for enhanced therapeutic potential and cancer immunotherapy.